VEGFA and renal cell carcinoma: Functional studies reveal that media from RCC monocytes facilitate angiogenesis that is reversed by blocking VEGF receptor 2 (VEGFR2), indicating that RCC monocytes exert a VEGF-dependent pro-angiogenic property [31].